Literature DB >> 12666851

Methylene tetrahydrofolate reductase gene and coronary artery disease.

M P Iqbal1, P M Frossard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12666851

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN： 0030-9982            Impact factor:   0.781


× No keyword cloud information.
  4 in total

Review 1.  Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control.

Authors:  J R Miranda-Massari; M J Gonzalez; F J Jimenez; M Z Allende-Vigo; J Duconge
Journal:  Curr Clin Pharmacol       Date:  2011-11

2.  Role of treatment-modifying MTHFR677C>T and 1298A>C polymorphisms in metformin-treated Puerto Rican patients with type-2 diabetes mellitus and peripheral neuropathy.

Authors:  Francisco J Jiménez-Ramírez; Liza M Castro; Clarymar Ortiz; Jennifer Concepción; Jessicca Y Renta; Raúl H Morales-Borges; Jorge R Miranda-Massari; Jorge Duconge
Journal:  Drug Metab Pers Ther       Date:  2017-03-01

3.  Association analyses suggest multiple interaction effects of the methylenetetrahydrofolate reductase polymorphisms on timing of menarche and natural menopause in white women.

Authors:  Pengyuan Liu; Yan Lu; Robert R Recker; Hong-Wen Deng; Volodymyr Dvornyk
Journal:  Menopause       Date:  2010 Jan-Feb       Impact factor: 2.953

4.  Polymorphisms in MTHFR, MS and CBS genes and homocysteine levels in a Pakistani population.

Authors:  Mohsin Yakub; Naushad Moti; Siddiqa Parveen; Bushra Chaudhry; Iqbal Azam; Mohammad Perwaiz Iqbal
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.